Advertisement

Topics

Cancer Corporate

06:59 EST 23rd February 2017 | BioPortfolio

IFM Therapeutics

IFM Therapeutics is a privately held biopharmaceutical company based in Boston, Massachusetts. The company was founded in 2015 by an international group of preeminent scientists and physicians who have spent decades understanding innate immunity and the role it plays in regulating the immune system. IFM’s team has discovered and developed small molecu...

DiaCarta, Inc.

DiaCarta is an innovative precision molecular diagnostic company headquartered in Richmond, California. The company has an ISO 13485-certified facility, which is used to develop, manufacture and market a range of cancer research and IVD products. DiaCarta specializes in genomic testing for biomarkers and offers clinical sample testing services in a CLIA-ce...

Iconic Therapeutics

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The company’s lead product candidate, ICON-1, is a novel fusion protein designed to address the basis of vision loss in AMD. By targeting inflammation and a...

Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research -- and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic canc...

Blue Earth Diagnostics Ltd.

Blue Earth Diagnostics is a molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need. Formed in 2014, Blue Earth Diagnostics is led by recognized experts in the clinical development and commercialization ...

Nativis Inc.

Founded in 2002 and headquartered in Seattle, WA, Nativis is a clinical-stage bio-electronics company. Nativis has invented and patented a groundbreaking technology that utilizes precisely targeted, ultra-low radio frequency energy (ulRFE) to specifically regulate metabolic pathways on the molecular and genetic levels – without chemicals, radiation or...

Agendia, Inc.

Agendia is a privately owned, leading molecular diagnostic company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decisions. Agendia’s breast cancer suite was developed using an unbiased gene selection by analyzing the complete human genome. This includes FDA-cleared MammaPr...

Tempus

Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and an...

Globavir Biosciences, Inc.

Globavir Biosciences, based in Los Altos, CA, is developing life-saving technologies for cancer and the diagnosis and treatment of some of the world’s most deadly viral diseases. To complement its world-class dengue diagnostic assays, Globavir is also developing GBV006, a powerful combination drug therapy, for the treatment of dengue fever.

Cue Biopharma, Inc.

Cue Biopharma™ (Cue) is an immunotherapy company developing biologics engineered to selectively communicate with disease-relevant T cell subsets to treat cancer and autoimmune disease. Cue biologics have the potential to be highly effective as monotherapies as well as synergistic with existing checkpoint inhibitors, while reducing collateral toxici...

Mattie Miracle Cancer Foundation

Oncoinvent AS

Oncoinvent AS is a privately held Norwegian company based in Oslo, Norway. The company is committed to developing new innovative products in order to provide better treatment options to cancer patients. The company's founders started Oncoinvent in 2010 with a view to designing better cancer treatments by applying known physical and chemical principles of s...

Neurotechnology Industry Organization

The Neurotechnology Industry Organization is the trade association that represents companies involved in neuroscience including software, drugs, devices, and diagnostics, brain research institutes, and patient advocacy groups across the world. Since NIO's founding in 2006, over 100 organizations have joined NIO to "give the brain a voice." For more informa...

HeritX

HeritX is the only organization focused solely on preventing inherited cancers, with an initial focus on inherited BRCA cancers. In 2015, we founded HeritX to apply our experience in cancer research, developing breakthrough therapies and global business to achieve this goal. Our mission is personal because our families are affected by inherited BRCA. Our c...

Kiadis Pharma N.V.

Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The Company believes that its innovative products have the potential to address the current risks and limitations connected with allo...

Cancer MoonShot 2020

OncoImmune, Inc.

OncoImmune (www.oncoimmune.com) is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel immunotherapies for cancer, inflammation and autoimmune diseases. OncoImmune entered into a license and option agreement in 2016 with Pfizer Inc. regarding ONC-392, a pre-clinical IO program. OncoI...

A1M Pharma

A1M Pharma develops a diagnostic method and a novel treatment for the damaging effects of pre-eclampsia, a condition that affects around 10 million pregnant women worldwide. This disorder is responsible for 76,000 maternal and 500,000 infant deaths each year. It is also the cause of 15 per cent of all premature births. Currently, there is no predictive diagnostic method or treatment for impairme...

Gadeta

Founded in 2015, Gadeta has developed a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell receptors (TCRs) with an enhanced anti-cancer reactivity. Gadeta’s new cell-based anti-cancer product called T Cells Engineered To Express A Defined Gamma Delta TCR (TEGs) has strong therap...

Biomoda

Biomoda, Inc. is a developmental stage company engaged in the business of developing biopharmaceutical technology to diagnose and treat human diseases. The Company currently licenses two patents in the U.S. On November 10, 1992, the Company licensed a patent for the detection of cancers of the lung. A second patent, dealing with treatment of cancers of the lung, was licensed on February 21, 1995...

Placon Therapeutics

Placon Therapeutics is a biotechnology company developing next-generation novel platinum medicines designed to improve the efficacy and side effect profile of today’s cytotoxic medicines that are widely used in cancer treatment. The company’s albumin-conjugating platinum drug candidates have long circulating half lives and preferentially accumula...

Neural Analytics Inc.

Neural Analytics is creating products and services to measure, diagnose and track brain health with a current focus on Traumatic Brain Injury (TBI). NA combines leading edge data science with medical robotics to empower first responders and clinicians to accurately assess mild to severe TBI, including concussions. NA’s devices are portable, reliable...

TME Research

TME is a network of clinicians, researchers, educators and companies whose core mission is to improve the quality and access to targeted breast cancer care by fostering high quality and comprehensive educational programs and resources. TME research is an extension of the TME mission and designs, executes and optimizes accrual in breast cancer and breast he...

Chronix Biomedical, Inc.

Chronix Biomedical is a molecular diagnostics company developing blood tests primarily for cancer, including companion diagnostics and tests for detecting minimal residual disease. Chronix is scaling up to offer its pioneering tests through its own laboratories under CLIA certification in North America and the CE mark in Europe. The Company’s initial ...

Antelope Valley Healthcare District

Antelope Valley Hospital, a 420-bed district hospital located in the city of Lancaster in northern Los Angeles County, has been serving the community for more than 60 years. The area’s only full-service hospital, AVH provides a full array of medical/surgical services, pediatric treatment, NICU, mental health, cancer care and more. It is a Level II tra...

Quick Search
Advertisement
 

review and buy Cancer market research data and corporate reports here